Alexandros Arvanitakis

Lund University — Sweden

Medicine · Health Sciences

4h-index160citations12works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Blood Coagulation and Thrombosis Mechanisms(4), Complement system in diseases(4), Hemophilia Treatment and Research(4), Coagulation, Bradykinin, Polyphosphates, and Angioedema(4), Blood groups and transfusion(3)

Publications12 total

Comparative clinical efficacy and safety of biosimilar <scp>ABP</scp> 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
American Journal of Hematology·2024· 6 citedOpen Access
[Sickle cell disease - common and dangerous complications].
PubMed·2024· 1 cited
Primary prophylaxis implementation and long‐term joint outcomes in Swedish haemophilia A patients
Haemophilia·2024· 4 citedOpen Access
Efficacy of Parallel and Crossover Analysis As Well As Pharmacokinetic Similarity Were Confirmed between ABP 959 and Eculizumab Reference Product in Patients with PNH
Blood·2023· 1 citedOpen Access
PB2059: SENSITIVITY AND SUBGROUP ANALYSES FURTHER SUPPORT CLINICAL SIMILARITY IN EFFICACY BETWEEN ABP 959 AND ECULIZUMAB REFERENCE PRODUCT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
HemaSphere·2023Open Access
Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health‐related quality of life in patients with severe haemophilia A
Haemophilia·2023Open Access
Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria
Blood·2022· 8 cited
Clinical outcome and adherence rate in Scandinavian patients with intermediate‐intensity prophylaxis before and after the switch of standard half‐life FVIII products to BAY 81–8973
Haemophilia·2022· 3 citedOpen Access
A comparison of MyPKFiT and WAPPS‐Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa
Haemophilia·2021· 9 citedOpen Access
RECURSION AND EVOLUTION: PART II
arXiv (Cornell University)·2020Open Access
Comprehensive Prospective Next Generation Sequencing of Acute Myeloid Leukemia
Blood·2015· 2 cited
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP
Blood·2013· 126 cited

Frequent Co-authors

Jan Astermark(4), Austin Kulasekararaj(4), Francesco Lanza(4), Satheesh Chonat(4), Haby Henary(4), Saskia Langemeijer(3), Vincent Chow(3), Jia Cao(3), Marianne Rissler(2), Thoas Fioretos(2), Erik Berntorp(2), Vladimir Hanes(2), Pål André Holme(2), Maria Askmyr(1), Helena Ågerstam(1), Nils Hansen(1), Sandra Gordon(1), Gunnar Juliusson(1), Johan Richter(1), Marcus Järås(1)